Medicare Advantage Home Assessment Follow-Up: A Diagnosis Found Only at the Home Visit

A Medicare Advantage home assessment diagnosis with no follow-up raises two questions: did the visit produce an unsupported diagnosis, or did the patient miss care for a condition they actually had? The Department of Health and Human Services’ Office of Inspector General has raised both concerns about diagnoses found only on assessment records. For a clinician, coder or vendor employee, the useful comparison starts with the form: what supported the diagnosis, what other providers recorded before and after the visit, and what the plan sent for payment. A home assessment program built around capturing diagnoses can leave a payment trail much clearer than the care trail.

What Does a Diagnosis With No Follow-Up Show?

The inspector general found no other visits, procedures, tests or supplies for assessment-only diagnoses in the encounter data for 1.7 million Medicare Advantage enrollees. Its comparison covered diagnoses reported only on health risk assessments or linked chart reviews, absent from other service records for 2022.

The inspector general’s October 2024 evaluation raised concerns about inaccurate diagnoses generating improper payments, or patients going without needed care for serious conditions. Those are different failures. In one, taxpayers pay for a condition the documentation does not support. In the other, the assessment identifies a care need that goes unmet.

For an insider considering a Medicare Advantage fraud case, the next question is what can resolve that difference. Does the form contain clinical support? Did another clinician confirm or contradict the finding? Does the comparison include the records of the providers who actually saw the patient? The patient’s history and the code sent for payment need to meet in the same inquiry.

What the Inspector General Found in the Assessment Records

In its 2020 report on health risk assessments, the inspector general estimated $2.6 billion in risk-adjusted payments for 2017 from diagnoses reported only on assessments and on no other encounter records. In-home assessments generated 80 percent of those estimated payments.

The later evaluation estimated $7.5 billion in payments for 2023 from diagnoses reported only on assessments and assessment-linked chart reviews, absent from other 2022 service records. In-home assessments and their linked chart reviews generated almost two-thirds of that estimate.

The inspector general recommended audits to validate diagnoses reported only on in-home assessments and their linked chart reviews. That validation is where the completed form and the wider medical record become decisive.

Matrix’s Comparison Reached Before and After the Visit

The Matrix allegations compared home-visit diagnoses with what other providers recorded during the visit year, the preceding two years and the subsequent two years. That gives an insider a concrete example of how a diagnosis can be examined across a patient’s care history.

Matrix Medical Network agreed to pay $36.5 million in a settlement announced on June 3, 2026. The government alleged that Matrix knowingly caused plans to submit false diagnoses for chronic conditions, including atrial fibrillation, rheumatoid arthritis and chronic obstructive pulmonary disease. Other providers who saw the beneficiaries frequently had not diagnosed those conditions anywhere in that comparison period.

The allegation reaches beyond a missed appointment after an assessment. It compares the vendor’s conclusion with the work of other clinicians who saw the same patient. The earlier records may explain whether the assessment revived an old condition. The later records may show whether anyone confirmed the new finding or recorded a contrary conclusion.

The sequence matters: what the other providers knew, what appeared at the home visit and what appeared afterward. A clinician can explain the finding. A reviewer can explain whether the diagnosis survived review. Together, those accounts can connect the patient’s record to the vendor’s output.

When the Assessment Form Conflicts With the Diagnosis

Cigna’s home-visit records put the clinical question inside the assessment itself. The Justice Department described a congestive heart failure diagnosis even though the form recorded a normal heart examination and an unremarkable cardiac review. The department also said the diagnoses at issue lacked support in the vendor forms and were not reported by another provider who saw the patient during the same year.

Cigna’s $37 million home-visit settlement, announced on September 30, 2023, formed part of a $172,294,350 national resolution covering several alleged practices. The local settlement announcement recorded factual admissions concerning the home-visit conduct. The clinical contradictions were inside the forms the program itself produced.

The department described providers who did not perform or order the testing or imaging needed to reliably diagnose the serious conditions reported. It also cited Cigna’s internal description of the program: administrative code capture rather than chronic or acute care management. A clinician sent into the home could report heart failure while Cigna prohibited treatment during the visit.

HealthFair agreed to pay $5 million in the same announcement that addressed Matrix. The government alleged that HealthFair providers diagnosed congestive heart failure and heart arrhythmia despite contradictory electrocardiogram and echocardiogram results. A test result, a clinical observation and an empty claims history offer different kinds of evidence. We examine what each says about the diagnosis the plan used.

The Clinical Note Can Change the Picture

A clinical note can tell a reviewer something that the diagnosis list leaves out. In the government’s complaint concerning DxID and Group Health Cooperative, the alleged conflict was between a major-depression code drawn from a problem list and the physician’s progress notes.

The complaint quoted the physician’s assessment, which called the depression resolved and transient, tied to his sister’s death, and noted that he had asked earlier in the year to come off his antidepressant and still felt good.

The government alleged that DxID coded the condition and Group Health Cooperative submitted it despite conflicting progress notes. In the complaint’s account, the physician had described what happened to the condition. Coding from the problem list lost that part of the story.

For an assessment diagnosis, we make the same comparison with the surrounding clinical notes: what was active, what had changed, and what the treating clinician actually concluded. Where a review finds conflicting information, the handling of additions and deletions becomes part of the payment question.

The Patient May Be the One Missing Out

Missing care is the other concern the inspector general raised. If a serious condition was supported at the assessment, the next question is whether the finding reached someone who could act on it. The report highlights the vulnerability of assessments conducted by plans or their vendors instead of the enrollee’s own provider.

We look for what happened to that specific finding: whether it reached the treating clinician, whether the clinician evaluated it and whether the record shows care for it. A referral or later clinical note may help answer that question. The completed assessment establishes what the visitor recorded. The later documentation can show what happened to the patient.

The treatment restrictions described by the Justice Department in Cigna’s case make the separation particularly clear. For a reviewer, the care question continues beyond the visit. For the patient, it can mean the plan has a new diagnosis to report while the need for care remains unresolved.

Payment Can Rise Without Evidence of More Care

The payment attached to a diagnosis reflects expected healthcare costs. Eligible diagnoses contribute to the enrollee’s risk score, which changes the plan’s payment. The assessment can therefore matter to revenue before there is any later treatment record.

The American Institutes for Research’s 2026 report, Medicare Advantage Fraud, Waste, and Abuse Policy Options, describes how organizations that own or closely control providers can influence coding through prompts, documentation incentives and retrospective chart reviews. It also describes a finding that makes the difference between recorded risk and observed care concrete:

That finding concerns corporate primary care practices. For a home-assessment inquiry, it supplies a reason to examine the coding process alongside the care history: the organization recording the conditions can influence how much illness appears in the payment data.

The Centers for Medicare & Medicaid Services has also changed which records can supply diagnoses for payment. Its 2027 payment announcement excludes diagnoses from unlinked chart review records, with an exception for beneficiaries switching between Medicare Advantage organizations from one year to the next.

What Happened to the Diagnosis After Review?

The assessment, the clinical comparison and the payment submission can show different outcomes for the same diagnosis. A clinician may dispute it. A reviewer may flag it. The plan’s submission history shows whether the code still reached Medicare or was later removed.

We connect those records with the people who can explain them. The visiting clinician knows what the assessment involved. Vendor staff know what the form and coding instructions required. Plan reviewers can explain the response to conflicting findings. The decision to keep, correct or remove the diagnosis connects their knowledge to the payment.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. We help you show both the unsupported diagnosis and what the organization did after learning about the problem.

You Know What Happened After the Visit

If you know how an unsupported home-assessment diagnosis reached payment or survived a clinical objection, speak with our whistleblower experts about that diagnosis and the decisions behind it. We work beside you to build your strongest case from the clinical history, the vendor’s instructions and the plan’s response, and bring in Medicare Advantage whistleblower lawyers who understand risk-adjustment coding.